Theriva Biologics, Inc. Operating Expenses
Theriva Biologics, Inc. (TOVX) reported Operating Expenses of $3.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-11
- Theriva Biologics, Inc. operating expenses for the quarter ending 2026-06-30 was $3.29M, a 74.91% decline year-over-year.
- Theriva Biologics, Inc. operating expenses for the quarter ending 2026-03-31 was $2.43M, a 45.05% decline year-over-year.
- Theriva Biologics, Inc. operating expenses for the quarter ending 2025-12-31 was $2.06M, a 54.96% decline year-over-year.
- Theriva Biologics, Inc. operating expenses for the quarter ending 2025-09-30 was $4.44M, a 43.70% decline year-over-year.
- Theriva Biologics, Inc. operating expenses for fiscal 2025 was $24.05M, a 8.71% decline from fiscal 2024.
- Theriva Biologics, Inc. operating expenses for fiscal 2024 was $26.35M, a 22.93% increase from fiscal 2023.
- Theriva Biologics, Inc. operating expenses for fiscal 2023 was $21.43M, a 0.70% decline from fiscal 2022.
- Theriva Biologics, Inc. operating expenses for fiscal 2022 was $21.58M, a 51.19% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.29M 10-Q · filed 2026-08-11 | $5.72M 10-Q · filed 2026-08-11 | $7.79M derived: sum of 3 quarters · filed 2026-08-11 | $12.22M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $2.43M 10-Q · filed 2026-05-05 | $4.49M derived: sum of 2 quarters · filed 2026-05-05 | $8.93M derived: sum of 3 quarters · filed 2026-05-05 | $22.06M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $6.50M derived: sum of 2 quarters · filed 2026-03-12 | $19.64M derived: sum of 3 quarters · filed 2026-08-11 | $24.05M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $4.44M 10-Q · filed 2025-11-12 | $17.57M derived: sum of 2 quarters · filed 2026-08-11 | $21.99M 10-Q · filed 2025-11-12 | $26.57M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $13.13M 10-Q · filed 2026-08-11 | $17.55M 10-Q · filed 2026-08-11 | $22.13M derived: sum of 3 quarters · filed 2026-08-11 | $30.02M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $4.42M 10-Q · filed 2026-05-05 | $9.00M derived: sum of 2 quarters · filed 2026-05-05 | $16.88M derived: sum of 3 quarters · filed 2026-05-05 | $25.37M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $12.47M derived: sum of 2 quarters · filed 2026-03-12 | $20.95M derived: sum of 3 quarters · filed 2026-03-12 | $26.35M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $7.89M 10-Q · filed 2025-11-12 | $16.38M derived: sum of 2 quarters · filed 2025-11-12 | $21.77M 10-Q · filed 2025-11-12 | $27.98M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $8.49M 10-Q · filed 2025-08-11 | $13.88M 10-Q · filed 2025-08-11 | $20.10M derived: sum of 3 quarters · filed 2025-08-11 | $24.32M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $5.39M 10-Q · filed 2025-05-14 | $11.61M derived: sum of 2 quarters · filed 2025-05-14 | $15.83M derived: sum of 3 quarters · filed 2025-05-14 | $21.65M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $10.44M derived: sum of 2 quarters · filed 2025-03-06 | $16.25M derived: sum of 3 quarters · filed 2025-03-06 | $21.43M 10-K · filed 2025-03-06 | |||
| 2023-09-30 | $4.22M 10-Q · filed 2024-11-12 | $10.04M derived: sum of 2 quarters · filed 2024-11-12 | $15.21M 10-Q · filed 2024-11-12 | $22.53M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $5.82M 10-Q · filed 2024-08-13 | $11.00M 10-Q · filed 2024-08-13 | $18.32M derived: sum of 3 quarters · filed 2024-08-13 | $23.30M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $5.18M 10-Q · filed 2024-05-07 | $12.49M derived: sum of 2 quarters · filed 2024-05-07 | $17.48M derived: sum of 3 quarters · filed 2024-05-07 | $22.51M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | $7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $12.30M derived: sum of 2 quarters · filed 2024-03-25 | $17.33M derived: sum of 3 quarters · filed 2024-03-25 | $21.58M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $4.99M 10-Q · filed 2023-11-13 | $5.01M 10-Q · filed 2022-11-10 | $10.01M derived: sum of 2 quarters · filed 2023-11-13 | $14.26M 10-Q · filed 2023-11-13 | $14.25M 10-Q · filed 2022-11-10 | $19.53M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $5.03M 10-Q · filed 2023-08-08 | $4.99M 10-Q · filed 2022-08-11 | $9.28M 10-Q · filed 2023-08-08 | $9.24M 10-Q · filed 2022-08-11 | $14.54M derived: sum of 3 quarters · filed 2023-08-08 | $17.82M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $4.25M 10-Q · filed 2023-05-11 | $9.52M derived: sum of 2 quarters · filed 2023-05-11 | $12.79M derived: sum of 3 quarters · filed 2023-05-11 | $15.99M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $8.54M derived: sum of 2 quarters · filed 2023-03-30 | $11.74M derived: sum of 3 quarters · filed 2023-03-30 | $14.27M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $3.27M 10-Q · filed 2022-11-10 | $6.47M derived: sum of 2 quarters · filed 2022-11-10 | $9.01M 10-Q · filed 2022-11-10 | $11.14M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $3.20M 10-Q · filed 2022-08-11 | $5.73M 10-Q · filed 2022-08-11 | $7.87M derived: sum of 3 quarters · filed 2022-08-11 | $9.98M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $2.54M 10-Q · filed 2022-05-16 | $4.67M derived: sum of 2 quarters · filed 2022-05-16 | $6.78M derived: sum of 3 quarters · filed 2022-05-16 | $9.67M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $4.24M derived: sum of 2 quarters · filed 2022-03-16 | $7.13M derived: sum of 3 quarters · filed 2022-03-16 | $10.16M 10-K · filed 2022-03-16 | |||
| 2020-09-30 | $2.11M 10-Q · filed 2021-11-03 | $5.00M derived: sum of 2 quarters · filed 2021-11-03 | $8.03M 10-Q · filed 2021-11-03 | $11.24M derived: sum of 4 quarters · filed 2021-11-03 | |||
| 2020-06-30 | $2.89M 10-Q · filed 2021-08-05 | $5.92M 10-Q · filed 2021-08-05 | $9.13M derived: sum of 3 quarters · filed 2021-08-05 | $14.37M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $3.03M 10-Q · filed 2021-05-05 | $6.24M derived: sum of 2 quarters · filed 2021-05-05 | $11.48M derived: sum of 3 quarters · filed 2021-05-05 | $15.12M derived: sum of 4 quarters · filed 2021-05-05 | |||
| 2019-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $8.45M derived: sum of 2 quarters · filed 2021-03-04 | $12.09M derived: sum of 3 quarters · filed 2021-03-04 | $15.66M 10-K · filed 2021-03-04 | |||
| 2019-09-30 | $5.24M 10-Q · filed 2020-11-10 | $8.88M derived: sum of 2 quarters · filed 2020-11-10 | $12.45M 10-Q · filed 2020-11-10 | $15.71M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $3.64M 10-Q · filed 2020-08-06 | $7.21M 10-Q · filed 2020-08-06 | $10.47M derived: sum of 3 quarters · filed 2020-08-06 | $14.79M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | $3.57M 10-Q · filed 2020-05-05 | $6.83M derived: sum of 2 quarters · filed 2020-05-05 | $11.15M derived: sum of 3 quarters · filed 2020-05-05 | $16.15M derived: sum of 4 quarters · filed 2020-05-05 | |||
| 2018-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $7.58M derived: sum of 2 quarters · filed 2020-02-20 | $12.58M derived: sum of 3 quarters · filed 2020-02-20 | $17.57M 10-K · filed 2020-02-20 | |||
| 2018-09-30 | $4.32M 10-Q · filed 2019-11-04 | $9.32M derived: sum of 2 quarters · filed 2019-11-04 | $14.31M 10-Q · filed 2019-11-04 | $20.10M derived: sum of 4 quarters · filed 2019-11-04 | |||
| 2018-06-30 | $5.00M 10-Q · filed 2019-08-08 | $9.99M 10-Q · filed 2019-08-08 | $15.78M derived: sum of 3 quarters · filed 2019-08-08 | $21.62M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $4.99M 10-Q · filed 2019-05-08 | $10.77M derived: sum of 2 quarters · filed 2019-05-08 | $16.61M derived: sum of 3 quarters · filed 2019-05-08 | $23.09M derived: sum of 4 quarters · filed 2019-05-08 | |||
| 2017-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $11.63M derived: sum of 2 quarters · filed 2019-02-27 | $18.10M derived: sum of 3 quarters · filed 2019-02-27 | $26.25M 10-K · filed 2019-02-27 | |||
| 2017-09-30 | $5.84M 10-Q · filed 2018-11-08 | $12.32M derived: sum of 2 quarters · filed 2018-11-08 | $20.47M 10-Q · filed 2018-11-08 | $30.67M derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $6.47M 10-Q · filed 2018-08-08 | $14.63M 10-Q · filed 2018-08-08 | $24.83M derived: sum of 3 quarters · filed 2018-08-08 | $33.98M derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2017-03-31 | $8.15M 10-Q · filed 2018-05-08 | $18.35M derived: sum of 2 quarters · filed 2018-05-08 | $27.51M derived: sum of 3 quarters · filed 2018-05-08 | $36.82M derived: sum of 4 quarters · filed 2018-05-08 | |||
| 2016-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $19.36M derived: sum of 2 quarters · filed 2018-02-22 | $28.67M derived: sum of 3 quarters · filed 2018-02-22 | $39.25M 10-K · filed 2018-02-22 | |||
| 2016-09-30 | $9.16M 10-Q · filed 2017-11-01 | $18.47M derived: sum of 2 quarters · filed 2017-11-01 | $29.05M 10-Q · filed 2017-11-01 | $40.44M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-06-30 | $9.31M 10-Q · filed 2017-08-03 | $19.89M 10-Q · filed 2017-08-03 | $31.29M derived: sum of 3 quarters · filed 2018-02-22 | $42.94M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-03-31 | $10.58M 10-Q · filed 2017-05-04 | $21.97M derived: sum of 2 quarters · filed 2018-02-22 | $33.62M derived: sum of 3 quarters · filed 2018-02-22 | $43.35M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $11.39M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $23.04M derived: sum of 2 quarters · filed 2018-02-22 | $32.77M derived: sum of 3 quarters · filed 2018-02-22 | $40.98M 10-K · filed 2018-02-22 | |||
| 2015-09-30 | $11.65M 10-Q · filed 2016-11-01 | $21.38M derived: sum of 2 quarters · filed 2016-11-01 | $29.59M 10-Q · filed 2016-11-01 | $36.69M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-06-30 | $9.73M 10-Q · filed 2016-08-03 | $17.94M 10-Q · filed 2016-08-03 | $25.04M derived: sum of 3 quarters · filed 2017-03-02 | $29.95M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2015-03-31 | $8.21M 10-Q · filed 2016-05-05 | $15.31M derived: sum of 2 quarters · filed 2017-03-02 | $20.22M derived: sum of 3 quarters · filed 2017-03-02 | $24.87M derived: sum of 4 quarters · filed 2017-03-02 | |||
| 2014-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $12.01M derived: sum of 2 quarters · filed 2017-03-02 | $16.66M derived: sum of 3 quarters · filed 2017-03-02 | $20.50M 10-K · filed 2017-03-02 | |||
| 2014-09-30 | $4.91M 10-Q · filed 2015-11-05 | $9.56M derived: sum of 2 quarters · filed 2015-11-05 | $13.40M 10-Q · filed 2015-11-05 | $17.67M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | $4.65M 10-Q · filed 2015-08-10 | $8.49M 10-Q · filed 2015-08-10 | $12.76M derived: sum of 3 quarters · filed 2016-03-10 | $16.13M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-03-31 | $3.84M 10-Q · filed 2015-05-11 | $8.11M derived: sum of 2 quarters · filed 2016-03-10 | $11.48M derived: sum of 3 quarters · filed 2016-03-10 | $13.94M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2013-12-31 | $4.27M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $7.64M derived: sum of 2 quarters · filed 2016-03-10 | $10.10M derived: sum of 3 quarters · filed 2016-03-10 | $12.34M 10-K · filed 2016-03-10 | |||
| 2013-09-30 | $3.37M 10-Q · filed 2014-11-14 | $5.83M derived: sum of 2 quarters · filed 2014-11-14 | $8.07M 10-Q · filed 2014-11-14 | $19.95M derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-06-30 | $2.46M 10-Q · filed 2014-08-14 | $4.70M 10-Q · filed 2014-08-14 | $16.59M derived: sum of 3 quarters · filed 2015-03-16 | $18.42M derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2013-03-31 | $2.24M 10-Q · filed 2014-05-15 | $14.13M derived: sum of 2 quarters · filed 2015-03-16 | $15.96M derived: sum of 3 quarters · filed 2015-03-16 | $17.68M derived: sum of 4 quarters · filed 2015-03-16 | |||
| 2012-12-31 | $11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $13.72M derived: sum of 2 quarters · filed 2015-03-16 | $15.45M derived: sum of 3 quarters · filed 2015-03-16 | $17.30M 10-K · filed 2015-03-16 | |||
| 2012-09-30 | $1.84M 10-Q · filed 2013-11-14 | $3.56M derived: sum of 2 quarters · filed 2013-11-14 | $5.41M 10-Q · filed 2013-11-14 | $8.20M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | $1.72M 10-Q · filed 2013-08-14 | $3.58M 10-Q · filed 2013-08-14 | $6.37M derived: sum of 3 quarters · filed 2013-08-14 | $7.24M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | $1.85M 10-Q · filed 2013-05-15 | $4.64M derived: sum of 2 quarters · filed 2013-05-15 | $5.51M derived: sum of 3 quarters · filed 2013-05-15 | $6.32M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-16 | $3.66M derived: sum of 2 quarters · filed 2013-04-16 | $4.46M derived: sum of 3 quarters · filed 2013-04-16 | $5.93M 10-K · filed 2013-04-16 | |||
| 2011-09-30 | $871.00K 10-Q · filed 2012-11-14 | $1.23M 10-Q · filed 2011-11-14 | $1.68M derived: sum of 2 quarters · filed 2012-11-14 | $3.14M 10-Q · filed 2012-11-14 | $4.26M 10-Q · filed 2011-11-14 | $3.44M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | $805.00K 10-Q/A · filed 2012-09-11 | $1.28M 10-Q · filed 2011-08-15 | $2.27M 10-Q/A · filed 2012-09-11 | $3.02M 10-Q · filed 2011-08-15 | $2.57M derived: sum of 3 quarters · filed 2012-09-11 | $3.60M derived: sum of 4 quarters · filed 2012-09-11 | |
| 2011-03-31 | $1.46M 10-Q · filed 2012-05-15 | $1.77M derived: sum of 2 quarters · filed 2012-05-15 | $2.79M derived: sum of 3 quarters · filed 2012-05-15 | $4.01M derived: sum of 4 quarters · filed 2012-05-15 | |||
| 2010-12-31 | $303.97K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-05-11 | $1.33M derived: sum of 2 quarters · filed 2012-05-11 | $2.55M derived: sum of 3 quarters · filed 2012-05-11 | $3.70M 10-K/A · filed 2012-05-11 | |||
| 2010-09-30 | $1.02M 10-Q · filed 2011-11-14 | $2.24M derived: sum of 2 quarters · filed 2011-11-14 | $3.39M 10-Q · filed 2011-11-14 | ||||
| 2010-06-30 | $1.22M 10-Q · filed 2011-08-15 | $2.37M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |